J3241 HCPCS code: Injection, teprotumumab-trbw, 10 mg
J3241 is the HCPCS Level II code for injection, teprotumumab-trbw, 10 mg. In 2024 Medicare paid an average of $253.58 per service for J3241 across 579,432 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 500 per day on DME suppliers. Medicare volume fell 14% from 2022 to 2024 (675,934 to 579,432 services). In 2024, about 637 clinicians billed Medicare for J3241 for 726 beneficiaries; Florida, California, Texas accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2020-10-01 |
| Last action effective | 2020-10-01 |
Who bills J3241 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 637 |
| Medicare beneficiaries | 726 |
| States with claims | 27 |
| Share of services in top 3 states (Florida, California, Texas) | 32% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3241, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 675,934 | 832 | $312.65 | $249.55 |
| 2023 | 620,409 | 757 | $313.88 | $250.06 |
| 2024 | 579,432 | 726 | $318.31 | $253.58 |
States with the most J3241 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 68,417 | $262.40 |
| California | 58,912 | $252.80 |
| Texas | 40,898 | $253.12 |
| New York | 32,207 | $236.79 |
| Tennessee | 27,314 | $238.39 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 500 | Prescribing Information |
| outpatient hospital claims | 500 | Prescribing Information |
| practitioner claims | 500 | Prescribing Information |
What changed for J3241
- 2020-10-01: J3241 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3241?
J3241 is the HCPCS Level II code for injection, teprotumumab-trbw, 10 mg. Short descriptor: "Inj. teprotumumab-trbw 10 mg".
How much does Medicare pay for J3241?
In 2024, the average Medicare payment was $253.58 per service (average allowed $318.31).
Does Medicare cover J3241?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3241 can be billed per day?
500 on DME suppliers; 500 on outpatient hospital claims; 500 on practitioner claims (NCCI medically unlikely edits).
Related J32 codes
- J3230 — Injection, chlorpromazine hcl, up to 50 mg
- J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3243 — Injection, tigecycline, 1 mg
- J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 — Injection, tildrakizumab, 1 mg
- J3246 — Injection, tirofiban hcl, 0.25 mg
- J3247 — Injection, secukinumab, intravenous, 1 mg
- J3250 — Injection, trimethobenzamide hcl, up to 200 mg
- J3260 — Injection, tobramycin sulfate, up to 80 mg
- J3262 — Injection, tocilizumab, 1 mg
- J3263 — Injection, toripalimab-tpzi, 1 mg
- J3265 — Injection, torsemide, 10 mg/ml
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3241
- Watch J3241 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3241
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.